PCLO.X
Recent Headlines
- PharmaCielo Makes Leap Across The Pond With 2 Large-Scale CBD, THC Extracts Sales Agreements
- XPhyto Therapeutics Announces Strategic Supply, Import and Distribution Agreement for the German Cannabis Market
- PharmaCielo Announces 30,000 Kg Cannabis Extract Agreement for German Market
- PharmaCielo Signs Pan-European Distribution Agreement for CBD Isolate and Broad-Spectrum CBD Oil
- PharmaCielo Added to XCAN - the Newly Created S&P/TSX Cannabis Index
- PharmaCielo Becomes First Cultivator Awarded Good Agricultural Practices (GAP) Global Certification for Colombian Medicinal-Cannabis Operations
- PharmaCielo Approved to Export CBD Isolate from Colombia to U.S.
- Those Who Purchased PharmaCielo (CVE:PCLO) Shares A Year Ago Have A 39% Loss To Show For It
- PharmaCielo Receives Acceptance from TSX Venture Exchange of Supply Agreement for Export of 2018 Farm Bill Compliant CBD Isolate to United States
- PharmaCielo Awarded Game-Changer Award by MJDaily
- PharmaCielo Announces Receipt of CAD$3.9 Million Secured Loan Repayment
- OTC Markets Group Welcomes PharmaCielo Ltd. to OTCQX
- PharmaCielo Graduates to OTCQX® Best Market and Secures DTC Eligibility
- /C O R R E C T I O N from Source -- PharmaCielo Ltd./
- PharmaCielo Announces Financial Results for the Three and Nine Months Ended September 30, 2019
- PharmaCielo Announces RSU Grant
- IIROC Trading Resumption - PCLO
- PharmaCielo Announces Termination of Scheme Implementation Agreement with Creso Pharma
- PharmaCielo Trading Halted Pending Update from Creso Pharma
- IIROC Trading Halt - PCLO
- IIROC Trading Resumption - PCLO
- PharmaCielo Provides Update on Proposed Acquisition of Creso Pharma
- PharmaCielo Announces Creso Pharma's Receipt of Australian Court Approval to Convene Meeting of Shareholders
- Horizons ETFs Rebalances Marijuana-Focused Index ETF Suite
- PharmaCielo Enters the U.S. with $3 Million Q4 Sales Agreement and Completes Introductory Shipments to Multi-state Distributor General Extract LLC
- PharmaCielo Announces Financial Results for the Second Quarter 2019
- PharmaCielo's Very First Commercial CBD Export from Colombia Lands in Europe
- PharmaCielo Expands Further Into Latin America With Sales Agreement to Supply CBD Extracts, Oils and Veterinary Products to Laboratorios Adler
- PharmaCielo Joins Canadian Market Cannabis Tracking and Verification Initiative
- PharmaCielo Colombia Holdings S.A.S. Appoints New and Diversified Board of Directors
- PharmaCielo Achieves Twelvefold Increase in Dried Cannabis Processing Capacity to Meet Global Demand for Medicinal Oil Extracts
- The Cannabis Sustainability Inquiry: Could Marijuana And Hemp Offer The Solution To The World's Toughest Environmental, Social, And Economic Problems?
- PharmaCielo to Begin Export of CBD Extracts from Colombia
- Cannabis Stock News Daily Roundup July 29
- PharmaCielo Completes Acquisition of Ubiquo Telemedicina
- PharmaCielo First to Receive Colombian Government Export Approval for Commercial Sale of CBD Isolate
- PharmaCielo Colombia Holdings S.A.S. Appoints Andres Felipe Botero as Chief Operations Officer
- PharmaCielo Ltd. (CVE:PCLO): When Will It Breakeven?
- Blueberries Medical Makes Significant Advances Towards Commercial Production & Provides Operational and Corporate Update
- PharmaCielo Announces Trading on the OTC Market
- IIROC Trading Resumption - PCLO
- PharmaCielo to Acquire International Cannabis Company Creso Pharma for A$122 Million
- IIROC Trading Halt - PCLO
- PharmaCielo Gears Up for U.S. Market Demand, Enlists Former Congressman and Medical Cannabis Advocate Dana Rohrabacher as a Special Advisor
- PharmaCielo Announces its Financial Results for the First Quarter 2019
- PharmaCielo Announces Results of AGM
- Ups and Downs in the Cannabis Space Last Week
- Cannabis Updates: New Listings, Price Action, and Ratings
- PharmaCielo Announces its Financial Results for the Fourth Quarter and Fiscal Year 2018
- Could The PharmaCielo Ltd. (CVE:PCLO) Ownership Structure Tell Us Something Useful?